gribio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title GRI
Description GRI Bio, Inc. and Vallon Pharmaceuticals Complete GRI Bio is a development stage biotech treating inflammatory, fibrotic and autoimmune disorders by regulating NKT cells to reset dysfunctional immune responses. We are initally focused on IPF and
Keywords GRI Bio, NKT, natural killer T cells, IPF, fibrosis
Server Information
WebSite gribio favicongribio.com
Host IP 69.195.112.203
Location United States
Related Websites
Site Rank
More to Explore
gribio.com Valuation
US$1,911
Last updated: 2023-05-18 01:15:58

gribio.com has Semrush global rank of 0. gribio.com has an estimated worth of US$ 1,911, based on its estimated Ads revenue. gribio.com receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 69.195.112.203. According to SiteAdvisor, gribio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,911
Daily Ads Revenue US$1
Monthly Ads Revenue US$52
Yearly Ads Revenue US$635
Daily Unique Visitors 14
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
gribio.com. A 7199 IP: 69.195.112.203
gribio.com. NS 21600 NS Record: ns2.justhost.com.
gribio.com. NS 21600 NS Record: ns1.justhost.com.
gribio.com. MX 14400 MX Record: 5 alt1.aspmx.l.google.com.
gribio.com. MX 14400 MX Record: 5 alt2.aspmx.l.google.com.
gribio.com. MX 14400 MX Record: 1 aspmx.l.google.com.
gribio.com. MX 14400 MX Record: 10 aspmx2.googlemail.com.
gribio.com. MX 14400 MX Record: 10 aspmx3.googlemail.com.
gribio.com. MX 14400 MX Record: 20 mail.gribio.com.
gribio.com. TXT 14400 TXT Record: v=spf1 +a +mx +ip4:173.254.30.244 +ip4:69.195.112.203 +include:_spf.google.com ~all
gribio.com. TXT 14400 TXT Record: v=spf1 +a +mx +ip4:173.254.30.244 +ip4:69.195.112.203 +include:justhost.com ~all
HtmlToTextCheckTime:2023-05-18 01:15:58
GRI Bio GRI BIO GRI BIO SCIENCE PROGRAMS TEAM NEWS INVESTORS GRI Bio, Inc. and Vallon Pharmaceuticals Complete Merger Click to read the press release Advancing Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune Diseases GRI Bio is a clinical stage biotech company focused on fundamentally changing the way inflammatory disease is treated by targeting NKT immune cells earlier in the inflammatory chain to interrupt disease progression more effectively. GRI Bio’s lead program, GRI-0621, is a small molecule RAR-βɣ dual agonist that inhibits the activity of human Type 1 invariant NKT (iNKT) cells, returning the immune system to homeostasis. Oral dosing of GRI-0621 has been shown to inhibit iNKT cells in patients and improve fibrosis in multiple disease models. GRI Bio is planning to launch a Phase 2a biomarker study evaluating GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) with data expected in 2024. GRI Bio’s
HTTP Headers
HTTP/1.1 200 OK
Date: Wed, 04 May 2022 08:26:33 GMT
Server: Apache
Upgrade: h2,h2c
Connection: Upgrade
Last-Modified: Fri, 09 Oct 2020 19:54:17 GMT
Accept-Ranges: bytes
Content-Length: 4635
Vary: Accept-Encoding
Content-Type: text/html
gribio.com Whois Information
Domain Name: GRIBIO.COM
Registry Domain ID: 1798208252_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.fastdomain.com
Registrar URL: http://www.fastdomain.com
Updated Date: 2022-04-17T18:40:38Z
Creation Date: 2013-05-01T21:40:20Z
Registry Expiry Date: 2023-05-01T21:40:20Z
Registrar: FastDomain Inc.
Registrar IANA ID: 1154
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.JUSTHOST.COM
Name Server: NS2.JUSTHOST.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-04T09:13:24Z <<<